Trypanothione
Also known as: N1,N8-bis(glutathionyl)spermidine, T(SH)2, Trypanothione disulfide (TS2), TSH2
Source Trypanothione at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Trypanothione is a spermidine-glutathione conjugate unique to trypanosomatid parasites (Leishmania spp., Trypanosoma brucei, T. cruzi), where it functions as the central thiol-redox metabolite. Because it is absent in mammalian cells and essential for parasite survival, both trypanothione itself and the enzymes of its biosynthesis and recycling (trypanothione reductase, trypanothione synthetase) are intensively studied as targets for antiparasitic drug discovery. It is not administered therapeutically but is a research biochemical and drug-design reference molecule.
Mechanism of Action
Trypanothione [N1,N8-bis(glutathionyl)spermidine] is a unique dithiol molecule found in trypanosomatid parasites. It is the primary low-molecular-weight thiol in these organisms, maintained in its reduced form by trypanothione reductase (TryR). It serves as the main redox buffer replacing the glutathione/glutathione reductase system found in host cells, detoxifying reactive oxygen species, hydroperoxides, and xenobiotics. It is not itself a drug but rather an endogenous metabolite and validated drug target in Leishmania, Trypanosoma brucei, and Trypanosoma cruzi.
Routes of Administration
Goals & Uses
- Drug target identification for African sleeping sicknessAntiparasitic ResearchHigh
- Drug target identification for Chagas diseaseAntiparasitic ResearchHigh
- Neglected tropical disease drug discoveryDrug DiscoveryHigh
- Drug target identification for leishmaniasisAntiparasitic ResearchHigh
- Redox biochemistry researchBasic ScienceHigh
Contraindications
No contraindications recorded yet.
Adverse Effects
No adverse effects recorded yet.
Drug Interactions
No drug interactions recorded yet.
Population Constraints
- Not applicable (research compound, not therapeutic)GeneralAbsolute
Regulatory Status
- European UnionUnapprovedNot an approved drug; research biochemical only
- United StatesUnapprovedNot an approved drug; research biochemical only
- United KingdomUnapprovedNot an approved drug; research biochemical only
Not approved as a therapeutic agent in any jurisdiction. Used exclusively as a research tool/biochemical standard and as a validated drug target scaffold.
Evidence & Sources
No sources recorded yet.
Frequently Asked Questions
What is Trypanothione?
Trypanothione is a spermidine-glutathione conjugate unique to trypanosomatid parasites (Leishmania spp., Trypanosoma brucei, T. cruzi), where it functions as the central thiol-redox metabolite. Because it is absent in mammalian cells and essential for parasite survival, both trypanothione itself and the enzymes of its biosynthesis and recycling (trypanothione reductase, trypanothione synthetase) are intensively studied as targets for antiparasitic drug discovery. It is not administered therapeutically but is a research biochemical and drug-design reference molecule.
What is Trypanothione used for?
Trypanothione is educationally associated with: Drug target identification for African sleeping sickness, Drug target identification for Chagas disease, Neglected tropical disease drug discovery, Drug target identification for leishmaniasis, Redox biochemistry research. Educational only — not medical advice.
How is Trypanothione administered?
Recorded routes of administration: Research Use Only.